For comments, suggestions
Created with Raphaël 2.1.0 02.08.2018 Filing date 21.10.2019 Validation fee payment 31.03.2020 (A1) Patent application published 11.08.2023 AGEPI application filing date 31.10.2023 (T2) Translation of the validated European patent 01.10.2025 02.08.2026 Valid until 03.08.2027 Renewal fee to be paid until 02.08.2038 Patent will expire on

Patent in force


(210)Number of the EPO application18759461
(220)Filing date of the EPO application2018.08.02
(80)EPO patent specification publication (B)EPB nr. 20/2023, 2023.05.17
(110)EPO patent number3601358
(11)Number of the documentMD 3601358 T2
(21)Number of the applicatione 2020 0147
(71)Name(s) of applicant(s), code of the countryAlector LLC, US;
(72)Name(s) of inventor(s), code of the countrySCHWABE Tina, US;
BROWN Eric, US;
KONG Philip, US;
TASSI Ilaria, US;
LEE Seung-Joo, US;
ROSENTHAL Arnon, US;
PEJCHAL Robert, US;
NIELSON Nels P., US;
(73)Name(s) of owner(s), code of the countryAlector LLC, US;
(54)Title of the inventionAnti-TREM2 antibodies and methods of use thereof
(13)Kind-of-document code T2
(51)International Patent Classification C07K 16/28 (2006.01.01); A61K 39/395 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2020.03.31
(49)Date of publication of the translation of the validated European patent specification2023.10.31
(30)Priority201762541019 P, 2017.08.03, US; 201862636095 P, 2018.02.27, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2018/045068, 2018.08.02
(87)International publicationWO 2019/028292, 2019.02.07
Up
/Inventions/details/3601358